Cargando…

Co-Expression of Multiple PAX Genes in Renal Cell Carcinoma (RCC) and Correlation of High PAX Expression with Favorable Clinical Outcome in RCC Patients

Renal cell carcinoma (RCC) is the most common form of kidney cancer, consisting of multiple distinct subtypes. RCC has the highest mortality rate amongst the urogenital cancers, with kidney renal clear cell carcinoma (KIRC), kidney renal papillary cell carcinoma (KIRP), and kidney chromophobe carcin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Lei, Li, Caiyun G., Almomani, Suzan N., Hossain, Sultana Mehbuba, Eccles, Michael R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380508/ https://www.ncbi.nlm.nih.gov/pubmed/37511191 http://dx.doi.org/10.3390/ijms241411432

Ejemplares similares

Urine Metabolomics for Renal Cell Carcinoma (RCC) Prediction: Tryptophan Metabolism as an Important Pathway in RCC
por: Liu, Xiaoyan, et al.
Publicado: (2019)

PAX Genes in Cancer; Friends or Foes?
por: Li, Caiyun G., et al.
Publicado: (2012)

Inhibition of angiogenic and non-angiogenic targets by sorafenib in renal cell carcinoma (RCC) in a RCC xenograft model
por: Yuen, J S P, et al.
Publicado: (2011)

Risk of infections in renal cell carcinoma (RCC) and non-RCC patients treated with mammalian target of rapamycin inhibitors
por: Kaymakcalan, M D, et al.
Publicado: (2013)

Systemic therapy in metastatic renal cell carcinoma (mRCC): an evidence-based recommendation of the German interdisciplinary RCC guidelines group
por: Grünwald, V., et al.
Publicado: (2022)

Crossing Paths in Human Renal Cell Carcinoma (hRCC)
por: Gallego, Guadalupe Aparicio, et al.
Publicado: (2012)

PAX7, PAX9 and RYK Expression in Cleft Affected Tissue
por: Vaivads, Mārtiņš, et al.
Publicado: (2021)

Identification of RCC Subtype-Specific microRNAs–Meta-Analysis of High-Throughput RCC Tumor microRNA Expression Data
por: Kajdasz, Arkadiusz, et al.
Publicado: (2021)

A New Treatment Landscape for RCC: Association of the Human Microbiome with Improved Outcomes in RCC
por: Piao, Xuan-Mei, et al.
Publicado: (2023)

Characteristics of Clear Cell Papillary Renal Cell Carcinoma (ccpRCC)
por: Rysz, Jacek, et al.
Publicado: (2021)

Molecular subtypes and prognosis in RCC
por: Beuselinck, Benoit, et al.
Publicado: (2015)

Open Surgery for Localized RCC
por: Vander Eeckt, Kathy, et al.
Publicado: (2007)

Clinical and Pathological Complete Remission in a Patient With Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: Is mRCC Curable With Targeted Therapy?
por: Shah, Amishi Y., et al.
Publicado: (2015)

Pivotal biomarker expression and drug screening in advanced ccRCC
por: Xiao, Wen, et al.
Publicado: (2020)

RCC2 Expression Stimulates ER-Positive Breast Tumorigenesis
por: Wang, Weiqi, et al.
Publicado: (2020)

Significance analysis of PAX8 expression in endometrial carcinoma
por: Hu, Shan, et al.
Publicado: (2022)

Safety and clinical efficacy of everolimus in the treatment of advanced renal cell carcinoma (RCC)
por: Shahani, Rohan, et al.
Publicado: (2010)

Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours
por: Wah, Tze M, et al.
Publicado: (2014)

OPtimal Treatment by Invoking biologic clusters in renal cell carcinoma (OPTIC RCC)
por: Beckermann, Kathryn, et al.
Publicado: (2023)

RCC1 Expression as a Prognostic Marker in Colorectal Liver Oligometastases
por: Deng, Yuxiang, et al.
Publicado: (2021)

PAX2 Expression in Ovarian Cancer
por: Song, Huijuan, et al.
Publicado: (2013)

Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC
por: Ribback, Silvia, et al.
Publicado: (2021)

Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro
por: Zieren, Richard C., et al.
Publicado: (2021)

Untangling ccRCC prognosis with SLINKY
por: Reinfeld, Bradley I., et al.
Publicado: (2017)

The Multifaceted Roles of RCC1 in Tumorigenesis
por: Ren, Xuanqi, et al.
Publicado: (2020)

Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC
por: Ross-Macdonald, Petra, et al.
Publicado: (2021)

Expression of RSK4, CD44 and MMP-9 is upregulated and positively correlated in metastatic ccRCC
por: Ma, Jing, et al.
Publicado: (2020)

PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis
por: Yun, Bo Seong, et al.
Publicado: (2022)

SMAD proteins directly suppress PAX2 transcription downstream of transforming growth factor-beta 1 (TGF-β1) signalling in renal cell carcinoma
por: Kaur, Gagandeep, et al.
Publicado: (2018)

Expression of PAX8 Target Genes in Papillary Thyroid Carcinoma
por: Rosignolo, Francesca, et al.
Publicado: (2016)

CT-based radiomics model for the prediction of genomic alterations in renal cell carcinoma (RCC)
por: Ebrahimi, Hedyeh, et al.
Publicado: (2023)

Giant Renal Cell Carcinoma (RCC): A Case Report of Delayed Diagnosis and Management
por: Villacreses, Camila A, et al.
Publicado: (2023)

Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis
por: Yuan, Lushun, et al.
Publicado: (2018)

Role of Nivolumab in the Modulation of PD-1 and PD-L1 Expression in Papillary and Clear Cell Renal Carcinoma (RCC)
por: Bialek, Joanna, et al.
Publicado: (2022)

Expression of PAX2 and PAX8 in Wilms Tumor: A Tissue Microarray-based Immunohistochemical Study
por: Sefidbakht, Salma, et al.
Publicado: (2021)

UnPAXing the Divergent Roles of PAX2 and PAX8 in High-Grade Serous Ovarian Cancer
por: Hardy, Laura R., et al.
Publicado: (2018)

Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC)
por: Bregni, Marco, et al.
Publicado: (2011)

Prognostic role of PHYH for overall survival (OS) in clear cell renal cell carcinoma (ccRCC)
por: Zhengqi, Qiu, et al.
Publicado: (2021)

Isolated Scalp Nodule in Patient with Undiagnosed RCC
por: Pan, David, et al.
Publicado: (2006)

Symptom burden among patients with Renal Cell Carcinoma (RCC): content for a symptom index
por: Harding, Gale, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_41eoolf7sf1ivhkk10ko4ejhad